Advanced Cancer Technologies Available in China
Bridging Global Patients to Advanced Oncology Care in China
Six categories of next-generation cancer treatment — several of which exist at only a handful of centers worldwide. Tap any technology to see how it works, who it may suit, and which of our partner hospitals offers it.
Boron Neutron Capture Therapy
A boron drug accumulates in tumor cells; a neutron beam triggers a local nuclear reaction that destroys them cell by cell. Usually only 1–2 sessions.
Details →Heavy Ion (Carbon-Ion) Therapy
Carbon beams deposit peak energy exactly at the tumor, with higher biological effectiveness than X-rays and fewer fractions — typically 4–16 sessions.
Details →Proton Therapy & Gamma Knife
Protons stop precisely at the tumor with little exit dose — a major advantage for pediatric tumors, brain, lung and prostate cancers, and re-irradiation.
Details →CAR-T Cell Therapy
Your own T-cells are engineered to recognize and attack cancer cells. China runs one of the world's largest CAR-T programs, at a fraction of US and European prices.
Details →Advanced Radionuclide Therapy
Targeted radiopharmaceuticals — Lu-177 PSMA, Lu-177 DOTATATE, I-131, Ra-223 and emerging alpha emitters — deliver radiation systemically to tumor cells.
Details →Y-90 Liver Tumor Radioembolization
Microspheres loaded with yttrium-90 are guided into the arteries feeding liver tumors, irradiating them from within with minimal damage to healthy liver.
Details →Quick Comparison
| Technology | Category | Often discussed for | Typical sessions |
|---|---|---|---|
| BNCT | Particle / neutron radiotherapy | Recurrent head & neck cancers; selected tumors | 1–2 |
| Heavy ion (carbon) | Particle radiotherapy | Lung, liver, pancreas, prostate, sarcomas | 4–16 |
| Proton | Particle radiotherapy | Pediatric, brain, lung, prostate, re-irradiation | ~15–30 |
| CAR-T | Cell & gene immunotherapy | Lymphoma, leukaemia, multiple myeloma | Single infusion |
| Radionuclide therapy | Systemic nuclear medicine | Prostate (PSMA), neuroendocrine, thyroid, bone metastases | Repeated cycles |
| Y-90 radioembolization | Interventional / locoregional | Primary liver cancer, liver metastases | 1–2 |
This table is a general orientation only. Suitability for any technology depends on your diagnosis, stage, prior treatments and overall health, and is determined solely by the treating hospital's medical team.
Which Technology Fits Your Case?
Send us your medical reports. Our team will review your situation with our partner hospitals and tell you honestly which options are realistic — and which are not.
Get a Free Case Review